1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Market Analysis by Type
  • 1.3.1 Overview: Global Mevalonolactone Consumption Value by Type: 2020 Versus 2024 Versus 2031
  • 1.3.2 ≥98%
  • 1.3.3 <98%
• 1.4 Market Analysis by Application
  • 1.4.1 Overview: Global Mevalonolactone Consumption Value by Application: 2020 Versus 2024 Versus 2031
  • 1.4.2 Cosmetics
  • 1.4.3 Others
• 1.5 Global Mevalonolactone Market Size & Forecast
  • 1.5.1 Global Mevalonolactone Consumption Value (2020 & 2024 & 2031)
  • 1.5.2 Global Mevalonolactone Sales Quantity (2020-2031)
  • 1.5.3 Global Mevalonolactone Average Price (2020-2031)

2 Manufacturers Profiles

• 2.1 Adeka
  • 2.1.1 Adeka Details
  • 2.1.2 Adeka Major Business
  • 2.1.3 Adeka Mevalonolactone Product and Services
  • 2.1.4 Adeka Mevalonolactone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.1.5 Adeka Recent Developments/Updates
• 2.2 Hubei Guangao Biotechnology
  • 2.2.1 Hubei Guangao Biotechnology Details
  • 2.2.2 Hubei Guangao Biotechnology Major Business
  • 2.2.3 Hubei Guangao Biotechnology Mevalonolactone Product and Services
  • 2.2.4 Hubei Guangao Biotechnology Mevalonolactone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.2.5 Hubei Guangao Biotechnology Recent Developments/Updates
• 2.3 Hubei Wande Chemical
  • 2.3.1 Hubei Wande Chemical Details
  • 2.3.2 Hubei Wande Chemical Major Business
  • 2.3.3 Hubei Wande Chemical Mevalonolactone Product and Services
  • 2.3.4 Hubei Wande Chemical Mevalonolactone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.3.5 Hubei Wande Chemical Recent Developments/Updates

3 Competitive Environment: Mevalonolactone by Manufacturer

• 3.1 Global Mevalonolactone Sales Quantity by Manufacturer (2020-2025)
• 3.2 Global Mevalonolactone Revenue by Manufacturer (2020-2025)
• 3.3 Global Mevalonolactone Average Price by Manufacturer (2020-2025)
• 3.4 Market Share Analysis (2024)
  • 3.4.1 Producer Shipments of Mevalonolactone by Manufacturer Revenue ($MM) and Market Share (%): 2024
  • 3.4.2 Top 3 Mevalonolactone Manufacturer Market Share in 2024
  • 3.4.3 Top 6 Mevalonolactone Manufacturer Market Share in 2024
• 3.5 Mevalonolactone Market: Overall Company Footprint Analysis
  • 3.5.1 Mevalonolactone Market: Region Footprint
  • 3.5.2 Mevalonolactone Market: Company Product Type Footprint
  • 3.5.3 Mevalonolactone Market: Company Product Application Footprint
• 3.6 New Market Entrants and Barriers to Market Entry
• 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

• 4.1 Global Mevalonolactone Market Size by Region
  • 4.1.1 Global Mevalonolactone Sales Quantity by Region (2020-2031)
  • 4.1.2 Global Mevalonolactone Consumption Value by Region (2020-2031)
  • 4.1.3 Global Mevalonolactone Average Price by Region (2020-2031)
• 4.2 North America Mevalonolactone Consumption Value (2020-2031)
• 4.3 Europe Mevalonolactone Consumption Value (2020-2031)
• 4.4 Asia-Pacific Mevalonolactone Consumption Value (2020-2031)
• 4.5 South America Mevalonolactone Consumption Value (2020-2031)
• 4.6 Middle East & Africa Mevalonolactone Consumption Value (2020-2031)

5 Market Segment by Type

• 5.1 Global Mevalonolactone Sales Quantity by Type (2020-2031)
• 5.2 Global Mevalonolactone Consumption Value by Type (2020-2031)
• 5.3 Global Mevalonolactone Average Price by Type (2020-2031)

6 Market Segment by Application

• 6.1 Global Mevalonolactone Sales Quantity by Application (2020-2031)
• 6.2 Global Mevalonolactone Consumption Value by Application (2020-2031)
• 6.3 Global Mevalonolactone Average Price by Application (2020-2031)

7 North America

• 7.1 North America Mevalonolactone Sales Quantity by Type (2020-2031)
• 7.2 North America Mevalonolactone Sales Quantity by Application (2020-2031)
• 7.3 North America Mevalonolactone Market Size by Country
  • 7.3.1 North America Mevalonolactone Sales Quantity by Country (2020-2031)
  • 7.3.2 North America Mevalonolactone Consumption Value by Country (2020-2031)
  • 7.3.3 United States Market Size and Forecast (2020-2031)
  • 7.3.4 Canada Market Size and Forecast (2020-2031)
  • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

• 8.1 Europe Mevalonolactone Sales Quantity by Type (2020-2031)
• 8.2 Europe Mevalonolactone Sales Quantity by Application (2020-2031)
• 8.3 Europe Mevalonolactone Market Size by Country
  • 8.3.1 Europe Mevalonolactone Sales Quantity by Country (2020-2031)
  • 8.3.2 Europe Mevalonolactone Consumption Value by Country (2020-2031)
  • 8.3.3 Germany Market Size and Forecast (2020-2031)
  • 8.3.4 France Market Size and Forecast (2020-2031)
  • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
  • 8.3.6 Russia Market Size and Forecast (2020-2031)
  • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

• 9.1 Asia-Pacific Mevalonolactone Sales Quantity by Type (2020-2031)
• 9.2 Asia-Pacific Mevalonolactone Sales Quantity by Application (2020-2031)
• 9.3 Asia-Pacific Mevalonolactone Market Size by Region
  • 9.3.1 Asia-Pacific Mevalonolactone Sales Quantity by Region (2020-2031)
  • 9.3.2 Asia-Pacific Mevalonolactone Consumption Value by Region (2020-2031)
  • 9.3.3 China Market Size and Forecast (2020-2031)
  • 9.3.4 Japan Market Size and Forecast (2020-2031)
  • 9.3.5 South Korea Market Size and Forecast (2020-2031)
  • 9.3.6 India Market Size and Forecast (2020-2031)
  • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
  • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

• 10.1 South America Mevalonolactone Sales Quantity by Type (2020-2031)
• 10.2 South America Mevalonolactone Sales Quantity by Application (2020-2031)
• 10.3 South America Mevalonolactone Market Size by Country
  • 10.3.1 South America Mevalonolactone Sales Quantity by Country (2020-2031)
  • 10.3.2 South America Mevalonolactone Consumption Value by Country (2020-2031)
  • 10.3.3 Brazil Market Size and Forecast (2020-2031)
  • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

• 11.1 Middle East & Africa Mevalonolactone Sales Quantity by Type (2020-2031)
• 11.2 Middle East & Africa Mevalonolactone Sales Quantity by Application (2020-2031)
• 11.3 Middle East & Africa Mevalonolactone Market Size by Country
  • 11.3.1 Middle East & Africa Mevalonolactone Sales Quantity by Country (2020-2031)
  • 11.3.2 Middle East & Africa Mevalonolactone Consumption Value by Country (2020-2031)
  • 11.3.3 Turkey Market Size and Forecast (2020-2031)
  • 11.3.4 Egypt Market Size and Forecast (2020-2031)
  • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
  • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

• 12.1 Mevalonolactone Market Drivers
• 12.2 Mevalonolactone Market Restraints
• 12.3 Mevalonolactone Trends Analysis
• 12.4 Porters Five Forces Analysis
  • 12.4.1 Threat of New Entrants
  • 12.4.2 Bargaining Power of Suppliers
  • 12.4.3 Bargaining Power of Buyers
  • 12.4.4 Threat of Substitutes
  • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

• 13.1 Raw Material of Mevalonolactone and Key Manufacturers
• 13.2 Manufacturing Costs Percentage of Mevalonolactone
• 13.3 Mevalonolactone Production Process
• 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

• 14.1 Sales Channel
  • 14.1.1 Direct to End-User
  • 14.1.2 Distributors
• 14.2 Mevalonolactone Typical Distributors
• 14.3 Mevalonolactone Typical Customers

15 Research Findings and Conclusion

16 Appendix

• 16.1 Methodology
• 16.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global Mevalonolactone market size was valued at US$ 8.8 million in 2024 and is forecast to a readjusted size of USD 16.3 million by 2031 with a CAGR of 6.9% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Mevalonolactone(CAS Number: 674-26-0) is a substance obtained by the dehydration of mevalonic acid and is rapidly converted back into mevalonic acid in water. Mevaolonic acid exists in equilibrium with mevalolactone, which is formed by internal condensation of mevalonic acid's terminal alcohol and carboxylic acid functional groups. Mevalonic acid is a key intermediate in the biosynthesis of terpenes and steroids. Mevalonolactone is known of inhibit HMG-CoA reductase activity. Mevalonolactone is mainly used in cosmetics field.
With increasing awareness of environmental issues, there is a significant trend toward bio-based and sustainable chemical production. The push for green chemistry practices is fostering research into more sustainable synthesis processes for producing MVL, including enzymatic and microbial fermentation pathways.
This report is a detailed and comprehensive analysis for global Mevalonolactone market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Mevalonolactone market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2020-2031
Global Mevalonolactone market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2020-2031
Global Mevalonolactone market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2020-2031
Global Mevalonolactone market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Mevalonolactone
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Mevalonolactone market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Adeka, Hubei Guangao Biotechnology, Hubei Wande Chemical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Mevalonolactone market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
≥98%
<98%
Market segment by Application
Cosmetics
Others
Major players covered
Adeka
Hubei Guangao Biotechnology
Hubei Wande Chemical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Mevalonolactone product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Mevalonolactone, with price, sales quantity, revenue, and global market share of Mevalonolactone from 2020 to 2025.
Chapter 3, the Mevalonolactone competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Mevalonolactone breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Mevalonolactone market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Mevalonolactone.
Chapter 14 and 15, to describe Mevalonolactone sales channel, distributors, customers, research findings and conclusion.